Σύγκριση μεθόδων

	Σχεδιασμός και Ανάλυση Πειραμάτων Δόσης-Απόκρισης	Φαρμακοκινητικό Διαμερισματικό Μοντέλο
Πεδίο	Πειραματικός Σχεδιασμός	Φαρμακομετρία
Οικογένεια	Hypothesis test	Regression model
Έτος προέλευσης	1994	1982
Δημιουργός	Classical pharmacology; formalized by ICH E4 (1994) and Ritz et al. (2015)	Gibaldi & Perrier
Τύπος	Nonlinear curve fitting and monotone contrast testing	Deterministic ODE-based pharmacokinetic model
Θεμελιώδης πηγή	Ritz, C., Baty, F., Streibig, J. C., & Gerhard, D. (2015). Dose-Response Analysis Using R. PLOS ONE, 10(12), e0146021.	Gibaldi, M., & Perrier, D. (1982). Pharmacokinetics (2nd ed.). Marcel Dekker. ISBN: 978-0-8247-1042-2
Εναλλακτικές ονομασίες	dose-response analysis, dose-response curve, Doz-Yanıt Tasarımı ve Analizi (Dose-Response), ED50 analysis	Mammillary Compartment Model, Multi-Compartment PK Model, Compartmental Analysis, Farmakokinetik Kompartman Modeli
Συναφείς	4	3
Σύνοψη	Dose-response design is a framework for planning and analysing experiments that characterise the relationship between the amount of a stimulus — such as a drug dose or a chemical concentration — and the magnitude of a biological or physiological response. Formalised in regulatory guidance by the ICH E4 guideline (1994) and extensively developed in the statistical literature by Ritz et al. (2015), the framework covers experiment design, four-parameter and five-parameter logistic curve fitting, key benchmark estimates (ED50/EC50, NOAEL, LOAEL), and monotone trend testing via the Williams procedure.	The pharmacokinetic compartment model represents the body as one or more hypothetical compartments interconnected by first-order rate processes, describing how a drug is absorbed, distributed, and eliminated over time. Systematized by Gibaldi and Perrier in 1982, these models use ordinary differential equations to characterize plasma concentration-time profiles. They are the cornerstone of drug development, dosage regimen design, and regulatory submission pharmacokinetic analyses.